Clinical Trials

BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Pancreatic Neoplasms

NCT03878524 2024-03-04

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Phase 1 Terminated

2 enrolled

Anemia, Blast Crisis, Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Thrombocytosis, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT01525082 2024-02-06

Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors

EndocrineGastrointestinal

20 enrolled 15 charts

Glucagonoma, Insulinoma, Pancreatic Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

NCT03376659 2024-02-05

Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma

Phase 1/2 Terminated

8 enrolled 14 charts

DermatologicGastrointestinalThoracic

Pancreatic Neoplasms, Colorectal Neoplasms

NCT06229340 2024-01-29

NТО-RAS

Phase 2 Recruiting

20 enrolled

Lung Neoplasms, Melanoma, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT05431582 2023-06-15

Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors

Phase 1 Withdrawn

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms

NCT00602602 2020-04-27

Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer

19 enrolled

Pancreatic Neoplasms

NCT00460174 2018-10-29

Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer

31 enrolled

Pancreatic Neoplasms

NCT00557492 2018-09-25

Efficacy of Neoadjuvant Chemoradiation for Potentially Resectable Pancreas Cancer

59 enrolled 13 charts

Neoplasms, Pancreatic Neoplasms

NCT00365144 2018-01-19

Bevacizumab and Erlotinib in Treating Patients With Metastatic Pancreatic Cancer That Did Not Respond to Previous Treatment With Gemcitabine

36 enrolled 10 charts

Pancreatic Neoplasms

NCT00366457 2017-05-15

Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer

32 enrolled 12 charts

Pancreatic Neoplasms

NCT00609765 2017-03-23

Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors

Phase 2 Terminated

1 enrolled 3 charts

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT00112528 2016-12-13

Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer

53 enrolled

Pancreatic Neoplasms

NCT00260364 2016-10-14

TARGET

Phase 1/2 Completed

44 enrolled

Pancreatic Neoplasms

NCT00614653 2016-08-01

Bevacizumab, Erlotinib and Capecitabine for Advanced Pancreatic Cancer

17 enrolled

Pancreatic Neoplasms

NCT01183663 2016-06-03

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

BreastCNSDermatologicGastrointestinalGenitourinaryOther hematologic neoplasmPlasma cell

180 enrolled

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioblastoma, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT00100815 2015-12-24

Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer

50 enrolled 10 charts

Pancreatic Neoplasms

NCT00417976 2015-10-01

Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer

42 enrolled 13 charts

Pancreatic Neoplasms

NCT00735306 2015-06-18

TART

12 enrolled 6 charts

Pancreatic Neoplasms

NCT00524069 2013-02-01

Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery

Phase NA Withdrawn

Pancreatic Neoplasms

NCT00126633 2012-09-17

Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer

53 enrolled

Pancreatic Neoplasms

NCT00410774 2012-09-17

Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery

Phase 1/2 Terminated

20 enrolled

Pancreatic Neoplasms

NCT00047710 2012-08-01

Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer

48 enrolled

Pancreatic Neoplasms

NCT00336648 2012-07-30

Preop Chemoradiation Resectable Pancreas

11 enrolled

Pancreatic Neoplasms

NCT00307723 2009-08-10

Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer

Phase 1/2 Terminated

52 enrolled

Pancreatic Neoplasms

NCT00222469 2008-07-09

Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer

50 enrolled